Weight Gain After Switch from Efavirenz-Based to Integrase Inhibitor-Based Regimens

BACKGROUND: Integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) offers persons living with HIV a potent new treatment option. Recently, local HIV clinicians noted weight gain in patients who switched from daily, fixed-dose efavirenz/tenofovir disoproxil fumarate/emtricitab...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Norwood, Jamison, Turner, Megan, Bofill, Carmen, Jenkins, Cathy, Bebawy, Sally, Rebeiro, Peter, Hulgan, Todd, Raffanti, Stephen, Haas, David, Sterling, Timothy R, Koethe, John
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631481/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.1094
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires